全文获取类型
收费全文 | 19871篇 |
免费 | 1507篇 |
国内免费 | 46篇 |
专业分类
耳鼻咽喉 | 212篇 |
儿科学 | 542篇 |
妇产科学 | 551篇 |
基础医学 | 2810篇 |
口腔科学 | 392篇 |
临床医学 | 1757篇 |
内科学 | 3861篇 |
皮肤病学 | 575篇 |
神经病学 | 2072篇 |
特种医学 | 630篇 |
外科学 | 2701篇 |
综合类 | 117篇 |
一般理论 | 8篇 |
预防医学 | 1795篇 |
眼科学 | 288篇 |
药学 | 1588篇 |
中国医学 | 56篇 |
肿瘤学 | 1469篇 |
出版年
2023年 | 115篇 |
2021年 | 306篇 |
2020年 | 277篇 |
2019年 | 367篇 |
2018年 | 434篇 |
2017年 | 374篇 |
2016年 | 388篇 |
2015年 | 436篇 |
2014年 | 528篇 |
2013年 | 971篇 |
2012年 | 1149篇 |
2011年 | 1160篇 |
2010年 | 683篇 |
2009年 | 652篇 |
2008年 | 1078篇 |
2007年 | 1014篇 |
2006年 | 1096篇 |
2005年 | 1012篇 |
2004年 | 978篇 |
2003年 | 899篇 |
2002年 | 849篇 |
2001年 | 417篇 |
2000年 | 386篇 |
1999年 | 397篇 |
1998年 | 251篇 |
1997年 | 199篇 |
1996年 | 201篇 |
1995年 | 218篇 |
1994年 | 186篇 |
1993年 | 177篇 |
1992年 | 273篇 |
1991年 | 304篇 |
1990年 | 259篇 |
1989年 | 285篇 |
1988年 | 253篇 |
1987年 | 232篇 |
1986年 | 211篇 |
1985年 | 239篇 |
1984年 | 218篇 |
1983年 | 160篇 |
1982年 | 165篇 |
1981年 | 139篇 |
1980年 | 84篇 |
1979年 | 131篇 |
1978年 | 112篇 |
1977年 | 127篇 |
1976年 | 91篇 |
1975年 | 93篇 |
1974年 | 94篇 |
1973年 | 97篇 |
排序方式: 共有10000条查询结果,搜索用时 140 毫秒
1.
Marike Gabrielson Mattias Hammarström Magnus Bäcklund Jenny Bergqvist Kristina Lång Ann H Rosendahl Signe Borgquist Roxanna Hellgren Kamila Czene Per Hall 《International journal of cancer. Journal international du cancer》2023,152(11):2362-2372
Tamoxifen prevents recurrence of breast cancer and is suggested for preventive risk-reducing therapy. Tamoxifen reduces mammographic density, a proxy for therapy response, but little is known about its effects in remodelling normal breast tissue. Our study, a substudy within the double-blinded dose-determination trial KARISMA, investigated tamoxifen-specific changes in breast tissue composition and histological markers in healthy women. We included 83 healthy women randomised to 6 months daily intake of 20, 10, 5, 2.5, 1 mg of tamoxifen or placebo. The groups were combined to “no dose” (0-1 mg), “low-dose” (2.5-5 mg) or “high-dose” (10-20 mg) of tamoxifen. Ultrasound-guided biopsies were collected before and after tamoxifen exposure. In each biopsy, epithelial, stromal and adipose tissues was quantified, and expression of epithelial and stromal Ki67, oestrogen receptor (ER) and progesterone receptor (PR) analysed. Mammographic density using STRATUS was measured at baseline and end-of-tamoxifen-exposure. We found that different doses of tamoxifen reduced mammographic density and glandular-epithelial area in premenopausal women and associated with reduced epithelium and increased adipose tissue. High-dose tamoxifen also decreased epithelial ER and PR expressions in premenopausal women. Premenopausal women with the greatest reduction in proliferation also had the greatest epithelial reduction. In postmenopausal women, high-dose tamoxifen decreased the epithelial area with no measurable density decrease. Tamoxifen at both low and high doses influences breast tissue composition and expression of histological markers in the normal breast. Our findings connect epithelial proliferation with tissue remodelling in premenopausal women and provide novel insights to understanding biological mechanisms of primary prevention with tamoxifen. 相似文献
2.
3.
4.
5.
6.
Timothee Dub Bolette Sborg Peter Henrik Andersen Thorolfur Gudnason Hanne Nkleby Ann Lindstrand Rose-Marie Carlsson Hanna Nohynek 《Euro surveillance : bulletin européen sur les maladies transmissibles = European communicable disease bulletin》2021,26(4)
Healthcare workers (HCWs) are at increased risk of both exposure and transmission of infectious disease. Two European Union (EU) directives state that health services are responsible for assessing their employees’ potential exposure to infectious diseases and offering immunisation free of charge. We assessed current policy for immunisation of HCWs and the availability of vaccine coverage data in the Nordic countries by surveying national vaccination experts in Denmark, Finland, Iceland, Norway and Sweden, as well as Swedish county medical officers (CMOs). All national experts and 17 of 21 Swedish CMOs responded. All EU countries had transposed the European directives into national law, while Norway and Iceland had similar national legislation. Recommendations or guidelines were issued in Denmark, Finland, Iceland, Norway and 15 of 17 responding Swedish counties. The range of diseases covered differed by countries and Swedish counties. HCW vaccine coverage data were not systematically collected; incomplete estimates were only available for Finland and two Swedish counties. In conclusion, recommendations or guidelines exist in the Nordic countries, but their impact cannot be assessed, as vaccine uptake among HCWs is not currently measured. Systematic collection of data is a necessary step towards improving HCW immunisation policy and practice in the Nordic countries. 相似文献
7.
Kragh Thomsen M. Rasmussen M. Fuursted K. 《世界核心医学期刊文摘》2006,2(9):2-22
2000年11月,作者得知从Aarhus大学医院皮肤科患者分离到的金黄色葡萄球菌对苯唑西林出现界线耐药(BORSA)。本文旨在描述其表型和基因型,并评估可能的传播途径以干预和阻止进一步蔓延。菌株由脉冲场凝胶电泳鉴定。几个感染控制方案的缺口显示患者间可直接或间接传播。皮肤屏障缺陷、皮肤病患者金黄色葡萄球菌的高携带率和院内双氯西林的高消耗率可促使传播。改善普通感染控制措施和重新评价院内抗生素政策后,该菌的暴发感染消失。 相似文献
8.
9.
Ulla Bergfeldt Kristian Borg Kjell Kullander Per Julin 《Journal of rehabilitation medicine》2006,38(3):166-171
OBJECTIVE: Analysis of the effects of a comprehensive focal spasticity program in adult patients. DESIGN: Retrospective study of an out-patient cohort. PATIENTS: One hundred patients were enrolled in the study (54 men and 46 women, mean age 41 years (SD 14). Cerebral palsy and stroke were equally common (80% in total). The remaining patients had miscellaneous diagnoses, including traumatic brain injury. METHODS: On average 230 units (SD 101) of botulinum toxin A Botox was given for 227 principal therapy targets chosen by the patient or the caregiver. One patient could have several targets for therapy. Administration of botulinum toxin was combined with 260 additional therapeutic interventions, most of which were forms of physical therapy. The effects were assessed after 6 weeks and compared with baseline functional abilities 1-2 weeks prior to therapy. RESULTS: Improvement was observed for 211 (93%) therapy targets, no change in 15 (7%), and impairment in 1, corresponding to an overall improvement in 90 patients (90%), 9 unchanged (9%) and worsening in 1. Spasticity assessment (Ashworth scale 0-4; 30 patients) showed a statistically significant improvement (median at baseline was 3 vs 2 after therapy, mean difference 1.2, p<0.001). CONCLUSION: Improvement was observed in >or=90% of patients and in their principal therapeutic targets in a cohort receiving their first focal spasticity treatment with botulinum toxin A and additional therapy. A strict strategy for patient selection and comprehensive management was followed. 相似文献
10.
J R Andersen G Lose M N?rgaard H Stimpel J T Andersen 《British journal of urology》1988,61(4):310-313
In a randomised, double-blind study, 20 women with idiopathic detrusor instability and associated symptoms were treated with terodiline 25 mg bd, placebo, and emepronium bromide 200 mg tds--each drug being given for 3 weeks with placebo as wash-out period before cross-over. The results were evaluated according to drug preference, frequency charts and elimination of detrusor instability on cystometry. Serum levels of both drugs were monitored as control of tablet intake. The preference for terodiline to placebo was statistically significant: 14/3 women (P less than 0.05), and the majority of women (12/4) preferred terodiline to emepronium. Terodiline also gave a small but significant reduction in 24 h micturition frequency and eliminated detrusor instability in almost 50% of the patients (P less than 0.05). Side effects were frequent but mild in all three treatment periods. It was concluded that terodiline offers an alternative in the treatment of female detrusor instability. 相似文献